Meaningful use (MU) Stage 2 requirements are accelerating EMR-specific patient portal adoption at an increasing rate, according to a new KLAS report.
The report, titled “Patient Portals 2013: On Track for Meaningful Use?”, finds that this increase is having a negative effect on best-of-breed vendors, as providers report that third-party solutions are not as well equipped as EMR offerings for the more engaging requirements of MU Stage 2.
The report showcases the performance of each of the patient portal offerings in the face of MU Stage 2 criteria, including patient engagement, ease of use, and support. The report also captures provider feedback on both the current states of the products and areas of future growth.
For further details, visit KLAS online.
